CoViD-19 Patient in Reims University Hospital in March to April 2020

CHU de Reims127 enrolled

Overview

Medical context: Follow-up of a retrospective cohort of 499 cases of CoViD-19, hospitalized at the University Hospital of Reims during the health crisis, prospectively up to two years of follow-up. Possible intervention for serological monitoring, leading to a change from category 3 to category 2 (French law on human person research) Aim of the study: To know the factors of gravity of CoViD-19, to know its prognostic factors, to see how the evolution of the treatments implemented have influenced the fate of the patients. Material and methods: Type of study: cohort study Population: Patients in the CoViD-19 cohort - Reims Calendar: September 2020 - July 2022 Expected results: Better knowledge of the cares of patients with CoViD-19

Study Type

OBSERVATIONAL

Enrollment

127

Conditions

Coronavirus Infections

Interventions

serologyBIOLOGICAL

biological blood samples withdrawn at 6, 12 and 24 months

Eligibility

Medical Language ↔ Plain English

Inclusion Criteria: * Patient hospitalized for CoViD-19 infection during the health crisis, in a short-stay service of Reims University Hospital and included in Covid-19 Cohort * Age \> 18 years * Patient who benefit from the national health insurance coverage * patient agree for participation (consent form signed) Exclusion Criteria: * Patient protected by law

Outcomes

Primary Outcomes

Health status in the 2 years after CoViD-19 diagnosis

status : dead or alive persistante respiratory distress (yes / no)

Time frame: 2 years follow up